Samuel Montgomery

Samuel Montgomery serves as an Honorary Research Associate within the UWA Medical School and the UWA Centre for Child Health Research, affiliated with The Kids Research Institute Australia in Perth, Western Australia. His research focuses on pediatric respiratory diseases, particularly cystic fibrosis, where he investigates airway immunology, microbial interactions, and inflammatory mechanisms in children.

Montgomery's primary research areas include cystic fibrosis pathogenesis, airway immunology, respiratory microbiology, and inflammation dynamics. He examines how viral infections like rhinovirus trigger airway epithelial damage through interleukin-1 pathways and studies nasal microbiome interactions in early-life respiratory responses, aiming to develop interventions for disease progression.

Analysis of his publications reveals a consistent trajectory from basic mechanisms of airway inflammation (2018-2020) toward clinical applications, including SARS-CoV-2 transmission dynamics (2023) and neonatal immune responses (2025). His work integrates molecular biology, clinical data, and microbiome analysis to bridge laboratory findings with patient outcomes in pediatric pulmonology.

He contributed as Investigator 03 to the Department of Health (Western Australia)-funded project \"Close encounters of the nasal mucosa: identifying mechanisms that determine host responses to infection in children following 'first contact' with respiratory viral pathogens\" (2023-2025), which examined early immune responses to respiratory viruses and received significant media attention across 8+ news outlets and social platforms.

Montgomery collaborates with the AREST CF consortium and WA Epithelial Research Program (WAERP), leveraging multidisciplinary teams to advance cystic fibrosis care through clinical data integration, microbiome profiling, and immune response mapping in pediatric airway research.